In our prior studies, we observed the persistence of the TKT-PARP1 interaction in HCC tumor samples [35] and X-Ray treated 293FT cells through the results of immunoprecipitation (IP) experiments coupled with mass spectrometry (MS) [9] (Supplementary Fig. S3A, B). This evidence concerns the gene PARP1 and hepatocellular carcinoma.